Bridging Specialties: Collaborative Strategies for Diagnosing and Managing Systemic Sclerosis
Wednesday, February 25, 2026
2-3 p.m. MDT
Add event to calendar
Chronic Rhinosinusitis with Nasal Polyps (CRSwNP) remains one of the most complex conditions to manage, with treatment options rapidly evolving in recent years. The introduction of biologic therapies has transformed the landscape of care, challenging clinicians to determine when surgery, biologics, or a combination of both offers the best outcomes. This live virtual meeting will bring together leading experts in otolaryngology and allergy/immunology to discuss current evidence, clinical experiences, and practical strategies for optimizing patient care. This interactive program will explore real-world case studies and multidisciplinary approaches to managing CRSwNP. Participants will gain valuable insights into effectively combining surgical and biologic treatments to achieve better long-term outcomes and enhance the quality of life for patients living with CRSwNP.
Target Audience:
Pulmonologists and rheumatologists as well as other advanced practice providers who treat patients with SSc.
Moderators:
Rebecca Keith, MD
Associate Professor
Department of Medicine
Division of Pulmonary, Critical Care & Sleep Medicine
Melissa Griffith, MD, RhMSUS
Associate Professor of Medicine
Division of Rheumatology
University of Colorado SOM
Accreditation and Designation Statements:
National Jewish Health is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
National Jewish Health designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Contact:
For questions, please call the Office of Professional Education at National Jewish Health at 303.398.1000 or 800.844.2305, or email ProEd@njhealth.org.
Support:
This activity is supported by an independent medical educational grant from Boehringer Ingelheim Pharmaceuticals, Inc.
Registration Information:
Add event to calendar